AERA THERAPEUTICS

With foundational technology developed in the labs of Feng Zhang, Ph.D., of the Broad Institute of MIT and Harvard, and Jason Shepherd, Ph.D., of the University of Utah, Aera was started by a distinguished set of industry leaders and company builders to expand the reach and impact of genetic medicines. Aera's mission is to harness enabling delivery technologies and precision payloads to develop transformative genetic medicines.

Also known as: Aera Therapeutics Inc.